| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.29 | 0.0001 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |